SF
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 23 | 10 | |||
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 19 | 8 | |||
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 10 | 6 | |||
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 6 | 4 | |||
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 11 | 5 | |||
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 7 | 5 | |||
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 107 | 20 | |||
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 60 | 35 | |||
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 78 | 44 | |||
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 149 | 41 | |||
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | 2022 | 65 | 13 | |||
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | 2021 | 226 | 69 | |||
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | 2021 | 219 | 211 | |||
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study | Transplant international | 2021 | 163 | 163 | |||
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | 2020 | 319 | 230 | |||
Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | 2020 | 328 | 2 | |||
Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | 2020 | 292 | 140 | |||
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 370 | 86 | |||
Identification of seven novel HLA class I and II alleles | HLA | 2018 | 195 | 0 | |||
Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | 2018 | 501 | 171 | |||
Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | 2018 | 307 | 1 | |||
Donor-specific antibodies C1q-binding: improvement in kidney graft management? | Transplant international | 2017 | 424 | 0 | |||
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 519 | 1 | |||
Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | 2017 | 494 | 0 | |||
Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | 2016 | 490 | 3 | |||
Analysis and monitoring of anti-HLA antibodies in solid-organ and stem cell transplantation : What to do? When should they be tested? | 2015 | 651 | 326 | ||||
Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | 2015 | 657 | 231 | |||
Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report | Human immunology | 2014 | 510 | 0 | |||
Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | 2014 | 638 | 2 | |||
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | 2013 | 647 | 354 | |||
Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | 2013 | 492 | 0 | |||
HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | 2012 | 606 | 1 | |||
Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | 2012 | 537 | 0 | |||
Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | 2012 | 637 | 0 | |||
Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes | European cytokine network | 2012 | 526 | 0 | |||
Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | 2011 | 535 | 668 | |||
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | 2011 | 657 | 0 | |||
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | 2011 | 597 | 0 | |||
Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | 2010 | 561 | 0 | |||
Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | 2010 | 597 | 0 | |||
Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | 2010 | 586 | 0 | |||
RANKing bone resorption versus inflammation: Infection makes the decision | IBMS boneKEy | 2010 | 471 | 244 | |||
Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | 2010 | 480 | 0 | |||
Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | 2009 | 522 | 81 | |||
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | 2009 | 577 | 0 | |||
Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | 2009 | 837 | 6 | |||
In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis | American journal of respiratory cell and molecular biology | 2008 | 703 | 1 | |||
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | 2008 | 782 | 0 | |||
Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | 2008 | 704 | 0 | |||
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Blood | 2008 | 529 | 0 | |||
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | 2008 | 522 | 164 | |||
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | 2007 | 173 | 84 | |||
Airway epithelial IL-15 transforms monocytes into dendritic cells | American journal of respiratory cell and molecular biology | 2007 | 565 | 1 | |||
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | 2006 | 474 | 261 | |||
Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | 2006 | 595 | 0 |